
|Videos|August 11, 2022
Researchers evaluate incontinence product usage and costs
Author(s)Urology Times staff
“[We] found that women were spending on average, nearly $35 a week on incontinence products in the highest symptom severity, which is a huge financial burden,” says Elisabeth M. Sebesta, MD.
Advertisement
In this video, Elisabeth M. Sebesta, MD, discusses the rationale and notable findings from the recent Neurourology and Urodynamics study, “The burdens of incontinence: Quantifying incontinence product usage and costs in women,” for which she served as a study author. Sebesta is an assistant professor of urology at Vanderbilt University Medical Center in Nashville, Tennessee.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants priority review to talazoparib plus enzalutamide for HRR gene-altered mCSPC
2
FDA grants tentative approval to generic olaparib tablets across previously approved indications
3
Published data support PSMA-PET–guided selection for 177Lu-rosopatamab tetraxetan in mCRPC
4
Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC
5











